Home / Stocks / NMRA

NMRA insider trading

Neumora Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$15.0M
Buys · last 90 days
0 · $0
Most recent buy
2025-10-29

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-10-29Burow Kristina
Director · 10% owner
Bought1,915,700$2.61$5.0M
2025-10-29ARCH Venture Fund XII, L.P.
10% owner
Bought1,915,700$2.61$5.0M
2025-10-29ARCH Venture Fund VII, L.P.
10% owner
Bought1,915,700$2.61$5.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Burow KristinaDirector · 10% owner1$5.0M
ARCH Venture Fund XII, L.P.10% owner1$5.0M
ARCH Venture Fund VII, L.P.10% owner1$5.0M

See NMRA on the chart

Every insider buy and sell for NMRA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.